The Changing Clinical Spectrum of Hypophysitis.
autoimmune
diabetes insipidus
hypopituitarism
immunotherapy
ipilimumab
pituitary
Journal
Trends in endocrinology and metabolism: TEM
ISSN: 1879-3061
Titre abrégé: Trends Endocrinol Metab
Pays: United States
ID NLM: 9001516
Informations de publication
Date de publication:
09 2019
09 2019
Historique:
received:
30
04
2019
revised:
16
06
2019
accepted:
21
06
2019
pubmed:
28
7
2019
medline:
28
7
2020
entrez:
27
7
2019
Statut:
ppublish
Résumé
Hypophysitis is a rare and potentially life-threatening disease, characterized by an elevated risk of complications, such as occurrence of acute central hypoadrenalism, persistent hypopituitarism, or extension of the inflammatory process to the neighboring neurological structures. In recent years, a large number of patients have been described as being affected by hypophysitis, due to the increased administration of immuno-chemotherapies. At the present time, the heterogeneous nature of hypophysitis diagnostic criteria and of the treatment protocols makes the management of affected patients difficult. We review the current data and evidence on primary and secondary hypophysitis, in order to suggest a diagnostic and therapeutic protocol that should be focused on a multidisciplinary approach, for reaching a prompt diagnosis and an appropriate and safe treatment.
Identifiants
pubmed: 31345630
pii: S1043-2760(19)30121-3
doi: 10.1016/j.tem.2019.06.004
pii:
doi:
Substances chimiques
Immunosuppressive Agents
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
590-602Informations de copyright
Copyright © 2019 Elsevier Ltd. All rights reserved.